Security key
92673K108
Vigil Neuroscience, Inc. - Common Stock (VIGL)
CUSIP: 92673K108
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 25,021,169
- Total 13F value
- $245,425,853
- Share change
- +92,100
- SEC-reported price per share
- $9.79
- Number of holders
- 39
- Value change
- +$901,731
- Number of buys
- 13
- Number of sells
- 9
- Shares outstanding
- 46,698,729
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
39
Top holders
10
VIGL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Vigil Neuroscience, Inc. SEC filings
Vigil Neuroscience, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92673K108
Recent filing periods:
Ownership snapshot
Top reported holders of VIGL - Vigil Neuroscience, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Atlas Venture Life Scienc...
Disclosed value leader
Atlas Venture Life Scienc...
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F
3/4/5
Lead comparable stake: 12%
Showing 1-6 of 15 holder rows.
Quick read
Atlas Venture Life Science Advisors, LLC leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Atlas Venture Life Science Advisors, LLC's linked filing trail.
Comparable ownership
Top 5
Atlas Venture Life Science Adviso...
12%
Northpond Ventures, LLC
9%
Artal Group S.A.
4.8%
CITADEL ADVISORS LLC
4.6%
Deep Track Capital, LP
4.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC |
13F
Company
|
12%
|
$72,960,925
5,836,874 shares
|
— | 31 Dec 2022 |
| Northpond Ventures, LLC |
13F
Company
|
9%
|
$52,681,225
4,214,498 shares
|
— | 31 Dec 2022 |
| Artal Group S.A. |
13F
Company
|
4.8%
|
$28,042,000
2,243,352 shares
|
— | 31 Dec 2022 |
| CITADEL ADVISORS LLC |
13F
Company
|
4.6%
|
$27,048,950
2,163,916 shares
|
— | 31 Dec 2022 |
| Deep Track Capital, LP |
13F
Company
|
4.5%
|
$26,302,175
2,104,174 shares
|
— | 31 Dec 2022 |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
Company
|
4.4%
|
$25,650,125
2,052,010 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
39
Shares
25,021,169
Rows available
39
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q1 2023 holders
39
Holder diff
38
| Investor | Q3 2025 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q3 2025 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend